Mylan receives FDA nod for generic Plendil
Mylan Pharmaceuticals has received final approval from the FDA for its ANDA for felodipine extended-release tablets as a treatment for hypertension. Felodipine is the generic version of AstraZeneca’s Plendil. Mylan aims to start shipping generic Plendil immediately.
- Mylan Receives FDA Approval For Nabumetone
- Ranbaxy receives provisional FDA nod for generic Nexium
- APP receives FDA nod for its two generics
- Barr Pharma receives FDA nod for generic Mirapex
